(Lumbrokinase)is a new enzyme supplement known to benefit the circulation and characteristics of the blood. It is a promising new tool for those seeking to protect from heart disease. it contains the enzyme lumbrokinase, which has been shown to assist with the breakdown of fibrin, a protein involved in blood clotting. It has proven valuable in acute, sub-acute, and chronic conditions associated with clotting tendencies and poor circulation.
Supplementing with lum helps to maintain an optimal environment for healthy circulation. It is also recommended for people using this supplementation . Long term toxicological tests in experimental animals showed that lumbrokinase is non toxic, free of side effects on the functioning of the heart, liver, kidney, respiratory and nervous systems.
Lumbrokinase is a new thrombolytic medicine, which is safe, non-toxic, with no obvious side.
Product Name: Earthworm Extract Lumbrukinase
Part Used: Earthworm
Active Ingredient: Lumbrukinase
Specification: Lumbrukinase 20000u/mg
Appearance: Yellow Fine Powder
| Analysis |
Standard |
Results |
| Appearance |
Light yellow to brown powder |
Complies |
| Odor |
Fishy smell |
Complies |
| Characteristic |
Hygroscopicity |
Complies |
| Loss on Drying |
≤5.0% |
3.8% |
| pH |
6.0-8.0 |
7.10 |
| As |
≤0.3mg/kg |
Complies |
| Pb |
≤0.5mg/kg |
Complies |
| Hg |
≤0.2mg/kg |
Complies |
| Cd |
≤0.3mg/kg |
Complies |
| Pesticide Residue |
|
|
| DDT |
≤0.1mg/kg |
Complies |
| Microbiology |
|
|
| Total Plate Count |
≤3000cfu/g |
Complies |
| Yeast & Mold |
<100/g |
Complies |
| E.Coli |
Negative |
Negative |
| Salmonella |
Negative |
Negative
|
IMAHERB BIOTECH SUPPLY Lumbrukinase
Benefits
So far, research on the health effects of lumbrokinase is limited. Still, there’s some evidence that it shows promise for the treatment of certain conditions. Here’s a look at several findings on the potential benefits:
Lumbrokinase may aid in the treatment of angina, according to a preliminary study published in the Journal of Alternative and Complementary Medicine in 2009. For the study, researchers assigned 10 people with both heart disease and angina to one month of treatment with lumbrokinase (in addition to their standard care). By the study’s end, angina symptoms had improved in six of the 10 patients.
Additionally, a preliminary study published in the Chinese journal Acta Pharmaceutica Sinica in 2006 found that lumbrokinase may shield heart health. In tests on rats, the study’s authors determined that lumbrokinase may protect against myocardial ischemia (a condition marked by blockage of the coronary arteries and decreased blood flow to the heart).
Preliminary research indicates that lumbrokinase may help stave off stroke. In a 2013 study published in the Chinese Medical Journal, for instance, 310 people hospitalized with ischemic stroke (a type of stroke that occurs when an artery in the brain becomes blocked) were treated with standard stroke treatment or standard treatment plus lumbrokinase capsules for one year. By the study’s end, the group receiving the lumbrokinase treatment had fewer ischemic strokes.
In a 2008 study from the European Journal of Pharmacology, tests on human cells determined that lumbrokinase may help guard against cerebral ischemia. (A condition marked by insufficient blood flow to the brain, cerebral ischemia can reduce the brain’s oxygen supply and, in turn, lead to stroke.) The study found that lumbrokinase may combat cerebral ischemia in part by preventing the formation of blood clots.
In addition, a small study published in Clinical Hemorheology and Microcirculation in 2000 found that lumbrokinase may be beneficial in the treatment of cerebral infarction (a type of ischemic stroke caused by the formation of a blood clot within the brain).
For the study, 31 people with cerebral infarction were treated with lumbrokinase, while another 20 patients were assigned to a control group. Results indicated that lumbrokinase may help treat cerebral infarction in part by decreasing fibrinogen.
3) Diabetes
An animal-based study published in Diabetes Research and Clinical Practicein 2013 suggests that lumbrokinase may help fight diabetic nephropathy (a kidney condition caused in part by poor control of diabetes . In an experiment involving diabetic rats, scientists observed that treatment with lumbrokinase helped protect against diabetic nephropathy (possibly by affecting certain enzymes thought to play a role in the kidney damage associated with this condition).
skype
Sales Manager
Rebekah
Rachel
Miranda
Camilla
Sales Manager